Real-time enrollment status for this metastatic pancreatic adenocarcinoma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:26 PM UTC
| NCT Number | NCT06524973 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Pancreatic Adenocarcinoma |
| Phase | NA |
| Target Enrollment | 136 participants |
| Active Locations | 22 sites in the US |
| Sponsor | City of Hope Medical Center |
| Last Updated on CT.gov | September 10, 2026 (Sep 10, 2026) |
As of October 12, 2026: Clinical trial NCT06524973 is currently recruiting participants. This na study for metastatic pancreatic adenocarcinoma is actively seeking new participants at 22 locations across the United States. The study is sponsored by City of Hope Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06524973 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06524973 was last updated Sep 10, 2026 (September 10, 2026). HelloStudys verifies this status automatically.